<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.1 20050630//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Biotechnol</journal-id><journal-title>BMC Biotechnology</journal-title><issn pub-type="epub">1472-6750</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1472-6750-5-28</article-id><article-id pub-id-type="pmid">16212654</article-id><article-id pub-id-type="doi">10.1186/1472-6750-5-28</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Avidin related protein 2 shows unique structural and functional features among the avidin protein family</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Hyt&#x000f6;nen</surname><given-names>Vesa P</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>veshyto@bytl.jyu.fi</email></contrib><contrib id="A2" contrib-type="author"><name><surname>M&#x000e4;&#x000e4;tt&#x000e4;</surname><given-names>Juha AE</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>juha.maatta@uta.fi</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Kidron</surname><given-names>Heidi</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>heidi.kidron@abo.fi</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Halling</surname><given-names>Katrin K</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>khalling@abo.fi</email></contrib><contrib id="A5" contrib-type="author"><name><surname>H&#x000f6;rh&#x000e4;</surname><given-names>Jarno</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jhorha@cc.jyu.fi</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Kulomaa</surname><given-names>Tuomas</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>tupesaku@cc.jyu.fi</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Nyholm</surname><given-names>Thomas KM</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>tnyholm@abo.fi</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Johnson</surname><given-names>Mark S</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>johnson4@abo.fi</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Salminen</surname><given-names>Tiina A</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>tiina.salminen@abo.fi</email></contrib><contrib id="A10" contrib-type="author"><name><surname>Kulomaa</surname><given-names>Markku S</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>markku.kulomaa@uta.fi</email></contrib><contrib id="A11" corresp="yes" contrib-type="author"><name><surname>Airenne</surname><given-names>Tomi T</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>tomi.airenne@abo.fi</email></contrib></contrib-group><aff id="I1"><label>1</label>NanoScience Center, Department of Biological and Environmental Science, P.O. Box 35 (YAB), FI-40014 University of Jyv&#x000e4;skyl&#x000e4;, Finland</aff><aff id="I2"><label>2</label>Department of Biochemistry and Pharmacy, &#x000c5;bo Akademi University, Tykist&#x000f6;katu 6 A, FI-20520, Turku, Finland</aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>7</day><month>10</month><year>2005</year></pub-date><volume>5</volume><fpage>28</fpage><lpage>28</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1472-6750/5/28"/><history><date date-type="received"><day>5</day><month>7</month><year>2005</year></date><date date-type="accepted"><day>7</day><month>10</month><year>2005</year></date></history><copyright-statement>Copyright &#x000a9; 2005 Hyt&#x000f6;nen et al; licensee BioMed Central Ltd.</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license><abstract><sec><title>Background</title><p>The chicken avidin gene family consists of avidin and several avidin related genes (<italic>AVR</italic>s). Of these gene products, avidin is the best characterized and is known for its extremely high affinity for D-biotin, a property that is utilized in numerous modern life science applications. Recently, the <italic>AVR </italic>genes have been expressed as recombinant proteins, which have shown different biotin-binding properties as compared to avidin.</p></sec><sec><title>Results</title><p>In the present study, we have employed multiple biochemical methods to better understand the structure-function relationship of AVR proteins focusing on AVR2. Firstly, we have solved the high-resolution crystal structure of AVR2 in complex with a bound ligand, D-biotin. The AVR2 structure reveals an overall fold similar to the previously determined structures of avidin and AVR4. Major differences are seen, especially at the 1&#x02013;3 subunit interface, which is stabilized mainly by polar interactions in the case of AVR2 but by hydrophobic interactions in the case of AVR4 and avidin, and in the vicinity of the biotin binding pocket. Secondly, mutagenesis, competitive dissociation analysis and differential scanning calorimetry were used to compare and study the biotin-binding properties as well as the thermal stability of AVRs and avidin. These analyses pinpointed the importance of residue 109 for biotin binding and stability of AVRs. The I109K mutation increased the biotin-binding affinity of AVR2, whereas the K109I mutation decreased the biotin-binding affinity of AVR4. Furthermore, the thermal stability of AVR2(I109K) increased in comparison to the wild-type protein and the K109I mutation led to a decrease in the thermal stability of AVR4.</p></sec><sec><title>Conclusion</title><p>Altogether, this study broadens our understanding of the structural features determining the ligand-binding affinities and stability as well as the molecular evolution within the protein family. This novel information can be applied to further develop and improve the tools already widely used in avidin-biotin technology.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Avidin from eukaryotic chicken together with streptavidin from prokaryotic <italic>Streptomyces avidinii </italic>share an unique property not seen in any other known proteins, an extremely high affinity (K<sub>d </sub>&#x02248; 10<sup>-15 </sup>M) to its natural ligand, the water-soluble vitamin D-biotin [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. High affinity and stability of the free and complex forms of (strept)avidin and biotin [<xref ref-type="bibr" rid="B1">1</xref>], the easy attachment of biotin to various target molecules [<xref ref-type="bibr" rid="B3">3</xref>] and the non-obtrusive chemical nature of biotin are currently exploited in numerous (strept)avidin-biotin based life science applications [<xref ref-type="bibr" rid="B4">4</xref>].</p><p>Avidin is postulated to exist throughout the oviparous vertebrates [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>] and has long been known to be the operational biotin-harvester in chicken egg-white, comprising about 0.05% of the total protein [<xref ref-type="bibr" rid="B1">1</xref>]. Recently, avidin related genes (<italic>AVR</italic>s) highly similar to avidin (91&#x02013;95% identity at the nucleotide level) have also been found in the chicken genome [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>], suggesting that in addition to avidin AVRs may also play a role in biotin-harvesting. <italic>AVR</italic>s seem to have functional promoter regions [<xref ref-type="bibr" rid="B11">11</xref>] and are located in close vicinity of the avidin gene on the chicken male-sex chromosome Z [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. Interestingly, the total number of <italic>AVR</italic>s is likely to vary between different individuals and even between different cells of the individual chicken [<xref ref-type="bibr" rid="B13">13</xref>]. The function of the <italic>AVR </italic>gene products is unknown, however, since the proteins encoded by them have not yet been isolated from chicken although mRNAs of <italic>AVR1, AVR2 </italic>and <italic>AVR3 </italic>are found during inflammation [<xref ref-type="bibr" rid="B11">11</xref>].</p><p>Since the avidin gene of chicken is the only cloned avidin gene within the vertebrates [<xref ref-type="bibr" rid="B14">14</xref>], structure-function and protein engineering studies have long been concentrated on it [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B24">24</xref>]. The three-dimensional structure of chicken avidin has already been determined, too [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. The bacterial homolog of avidin, streptavidin, is also well characterized: the gene encoding steptavidin has been cloned [<xref ref-type="bibr" rid="B27">27</xref>], its structure solved [<xref ref-type="bibr" rid="B28">28</xref>] and several studies on the biochemical properties and protein engineering of streptavidin have been reported [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B34">34</xref>].</p><p>In order to characterize the proteins encoded by the <italic>AVRs</italic>, avidin related proteins (AVRs) have recently been produced in insect cells using a baculovirus expression system and have been demonstrated to be functional biotin-binding proteins like chicken avidin [<xref ref-type="bibr" rid="B35">35</xref>]. AVRs do, however, show unique features when compared to avidin. The AVRs differ from avidin, with respect to glycosylation and charge properties, and all AVRs except AVR2 contain an uneven number of cysteine residues in their sequence, which can form inter-subunit disulphide bridges in addition to the intra-subunit disulphide bridges also seen in avidin [<xref ref-type="bibr" rid="B35">35</xref>]. Interestingly, the biotin-binding affinities of AVRs have been reported to vary over a wide range of values, AVR4 being almost as efficient a biotin binder as avidin [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>] and AVR2 showing the lowest affinity for biotin [<xref ref-type="bibr" rid="B35">35</xref>]. AVRs, like avidin, have been found to be very stable proteins, too; AVR4 has clearly higher thermal stability than avidin [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>]. Recently, we have been able to produce avidin and some AVRs in <italic>Escherichia coli</italic>, too [<xref ref-type="bibr" rid="B37">37</xref>]. The 3D-structure of AVR4 has been recently determined [<xref ref-type="bibr" rid="B38">38</xref>], and we have been able to produce chimeric forms of avidin and AVR4, which retained their high biotin affinity and showed improved thermal stability [<xref ref-type="bibr" rid="B39">39</xref>].</p><p>In this study, we have determined the high-resolution X-ray crystal structure of AVR2 in complex with the natural ligand, D-biotin. By using site-directed mutagenesis and recombinant expression techniques combined with structural studies, we have been able to characterize some of the structural factors responsible for the varying biochemical properties of the members of the chicken avidin protein family. The results may be utilized in avidin protein engineering aiming to fine-tune the ligand binding properties and thermal stability of AVRs and their chimeric forms in experiments needed to expand the tools available in the area of avidin-biotin technology. This study provides insight into the molecular evolution within the avidin family, too.</p></sec><sec><title>Results</title><sec><title>Production and mutagenesis of proteins</title><p>Several different AVRs, AVR2, AVR2(I109K), AVR4(K109I), AVR6, and a novel avidin mutant K111I, were efficiently expressed either in insect cells or using a bacterial expression system as summarised in Table <xref ref-type="table" rid="T1">1</xref>&#x000a0;[<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. Since wild type AVR6 was found to form oligomers in solution <italic>via </italic>disulphide bridges (data not shown), Cys-58 of AVR6 was mutated to Ser based on the alignment of AVR6 with AVR2 and AVR4 (Figure <xref ref-type="fig" rid="F1">1</xref>). The resulting protein AVR6(C58S) (hereafter referred to AVR6), as well as all of the other studied proteins, were found to form avidin-like tetramers according to analysis by size exclusion chromatography (Table <xref ref-type="table" rid="T2">2</xref>) and confirmed to be pure and homogenous using SDS-PAGE. The elution time of AVR2 was slightly different from that of avidin and of the other studied AVRs, which can partially be explained by the different charge properties of these proteins: AVR2 has a theoretical isoelectric point of 4.7 compared to 9.6 for AVR4, 6.9 for AVR6 and 9.7 for avidin. The effect of glycosylation is also clearly seen by the varying elution times in gel filtration analysis (Table <xref ref-type="table" rid="T2">2</xref>) for AVR2-b produced in bacteria (no glycosylation) and from insect cells (two potential glycosylation sites; both utilized to some extent [<xref ref-type="bibr" rid="B35">35</xref>]).</p><p>Purification of AVR2 and AVR6 on the 2-iminobiotin column was inefficient and therefore biotin affinity chromatography was used to isolate these proteins. In order to confirm the quality of the protein and correct cleavage of the bacterial signal peptide used in the production of AVRs in <italic>E. coli</italic>, the molecular weight of AVR2-b was determined using ESI-MS. The M<sub>r </sub>(14310.0 &#x000b1; 0.3 Da) determined from the experimental data using four charge states correlates well with the expected M<sub>r </sub>of 14307.8 Da. The final product from <italic>E. coli </italic>expression carries three additional residues (QTV) at the N-terminus as previously reported for avidin produced using the same method [<xref ref-type="bibr" rid="B37">37</xref>].</p><p>In a previous study, the K109I mutation of AVR2 was hypothesised to be at least partially responsible for the lower biotin-binding affinity of AVR2 when compared to other AVRs and avidin [<xref ref-type="bibr" rid="B35">35</xref>]. In order to validate this suggestion, we subjected AVRs to mutagenesis. The mutation I109K was introduced into AVR2 to increase its biotin-binding affinity. Likewise, the mutation Lys&#x02192;Ile was introduced into both AVR4 and avidin in order to cross-validate the hypothesis and lower the biotin-binding affinity of AVR4 and avidin. Gel filtration analysis showed that all of the mutated proteins corresponded to tetramers (Table <xref ref-type="table" rid="T2">2</xref>).</p></sec><sec><title>X-ray structure of AVR2</title><p>The X-ray structure of AVR2-b in complex with D-biotin was determined at 1.4 &#x000c5; resolution. The structure determination statistics are summarized in Table <xref ref-type="table" rid="T3">3</xref>. As expected based on the sequence alignment (Figure <xref ref-type="fig" rid="F1">1</xref>), AVR2 has an overall three-dimensional structure similar to those of avidin [PDB:1AVD] [<xref ref-type="bibr" rid="B26">26</xref>] and AVR4 [PDB: 1Y52] [<xref ref-type="bibr" rid="B38">38</xref>]. Each monomer in the homotetrameric protein has a &#x003b2;-barrel fold of eight &#x003b2;-strands with one end of the barrel adapted to bind D-biotin (Figure <xref ref-type="fig" rid="F1">1C</xref>).</p><p>Although AVR2 shares many structural features with avidin and AVR4, there are clear differences in their functional properties (Table <xref ref-type="table" rid="T2">2</xref>, Figure <xref ref-type="fig" rid="F4">4</xref>). The most distinctive structural differences are found around the terminal carboxylate group of D-biotin. In avidin, atom O10B of the terminal carboxylate group of D-biotin is hydrogen bonded to the backbone nitrogen atoms of Ala-39 and Thr-40 of the L3,4 loop [<xref ref-type="bibr" rid="B26">26</xref>], whereas in AVR4 there is only one polar contact between the O10B atom and the backbone nitrogen atom of Asp-39 of the L3,4 loop [<xref ref-type="bibr" rid="B38">38</xref>]. In AVR2, the O10B atom of D-biotin forms an additional hydrogen bond to the NE2 atom of Gln-97. Moreover, in avidin, the O10A atom of the carboxylate group of biotin is hydrogen bonded to the OG atoms of Ser-73 and Ser-75, while in AVR2 and AVR4 there is only one hydrogen bond to the OG atom of Ser-71 (equivalent to Ser-73 in avidin).</p><p>A few differences are also found around the central aliphatic segment and the bicyclic ring system of D-biotin. Leucine in avidin (Leu-99) and AVR4 (Leu-97) is replaced by glutamine in AVR2 (Gln-97), and threonine in avidin (Thr-77) and AVR4 (Thr-75) is replaced by Ser-75 in AVR2. The side-chain atoms of Gln-97 of AVR2 not only interact with the valeryl segment of D-biotin, as in the case of the corresponding Leu in avidin and AVR4, but also with the carboxylate group of D-biotin (see above). The corresponding residue in AVR4 and avidin is leucine, but glutamine is also found aligned at the equivalent position in other AVRs. The presence of the polar head group of Gln-97 in AVR2 also affects the type and conformation of the neighbouring residues, such as Ser-73, Leu-99 and Arg-112 as well as Ile-109 from another subunit. These residues line the entrance of the biotin-binding pocket: i) Ser-73 of AVR2 has two alternative rotamers unlike in the X-ray structure of avidin and AVR4, ii) Leu-99 of AVR2 is replaced by Ser-101 in avidin (Ser-99 in AVR4), iii) Arg-112 of AVR2 and AVR4 form a salt bridge with Asp-39 from the L3,4 loop, but Arg-112 has a different conformation in AVR2 than in AVR4 (in avidin the corresponding ARG-114 does not form a salt bridge with any of the residues from the L3,4 loop) and iv) Ile-109 of AVR2 is substituted by Lys-111 in avidin and by Lys-109 in AVR4. In addition, Ile-109 of AVR2 is located next to Trp-108, a residue known to be important for biotin binding [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B30">30</xref>], but Ile-109 does not appear to alter the conformation of this residue significantly in comparison to avidin and AVR4. All of these differences are located at the open end of the biotin-binding pocket and are very likely responsible for the varying biotin binding properties of avidin, AVR2 and AVR4. Moreover, although D-biotin adopts a very similar conformation in avidin, AVR2 and AVR4, the biotin-binding network is not identical (Figure <xref ref-type="fig" rid="F2">2</xref>).</p><p>The 1&#x02013;3 subunit interface (numbering according to Ref. [<xref ref-type="bibr" rid="B25">25</xref>]) is also markedly different in amino acid composition in AVR2 in comparison with avidin and AVR4. In avidin, the subunit contacts are established between the hydrophobic amino acid residues Met-96, Val-115 and Ile-117 [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>], which are in contact with the same set of residues from a neighbouring subunit. In AVR2, only valine (Val-113 in the AVRs) is conserved, while Met-96 and Ile-117 of avidin are respectively substituted by the hydrophilic residues Lys-94 and Asn-115 in AVR2 (Figure <xref ref-type="fig" rid="F1">1A</xref>). In the crystal structure of AVR2, the side chain of Lys-94 can exist in two alternate rotamers, which are hydrogen bonded either to the side-chain oxygen atom of Asn-115 or to the main-chain oxygen of Val-113, both from a neighbouring subunit (Figure <xref ref-type="fig" rid="F3">3</xref>). Asn-115 is also in contact with Asn-115 from a neighbouring subunit. In AVR4, Ile-117 of avidin is substituted by Tyr-115, the latter interacting strongly with Tyr-115 of an adjacent subunit and through a hydrogen bond to Lys-92 [<xref ref-type="bibr" rid="B38">38</xref>].</p></sec><sec><title>Comparative analysis of avidin family proteins</title><p>Previously, it has been found that AVR6 forms intermonomeric disulphide bridges [<xref ref-type="bibr" rid="B35">35</xref>]. Gel filtration analysis of AVR6 revealed that these disulphide bonds are formed between tetramers, thus causing further oligomerization of the protein (not shown). Consequently, we introduced the C58S mutation into AVR6, which successfully blocked oligomerisation, and used this mutated protein form in the comparative analyses in the present study.</p><p>The overall charge of AVR2 (pI &#x02248; 5) is very different when compared to that of avidin and AVR4 (pI &#x02248; 10). The number of ionic bonds in avidin is seven per subunit, whereas three salt bridges are seen in AVR4 [<xref ref-type="bibr" rid="B38">38</xref>]. In the AVR2-biotin complex, four intra-subunit salt bridges are detected: Asp-39-Arg-112, Glu-89-Arg-120, Lys-92-Asp-117 and Arg-98-Asp-107.</p></sec><sec><title>Biotin dissociation analysis</title><p>Of the proteins studied, the fastest [<sup>3</sup>H]biotin dissociation rate was found with AVR2, while the slowest rate was measured for avidin (Figure <xref ref-type="fig" rid="F4">4</xref>). Ile-109 is found close to the biotin-binding site in AVR2, whereas all other proteins in avidin family [<xref ref-type="bibr" rid="B35">35</xref>] have lysine at the equivalent position. In order to test the effect of Ile-109 on the biotin dissociation rate, the AVR2(I109K) mutant was produced. The resulting mutant had a significantly slower dissociation rate than the wild-type protein. AVR6, in turn, showed a dissociation rate constant in between the values observed for the two AVR2 forms. The dissociation rate constant for AVR4, measured in a previous study [<xref ref-type="bibr" rid="B39">39</xref>], was somewhat higher when compared to that of avidin. When Lys-109 of AVR4 was mutated to isoleucine according to the sequence of AVR2, the rate of dissociation increased as expected, but biotin binding of the resulting protein was still stronger than for the mutated AVR2 form. Similarly, the analogous mutation K111I in avidin increased the biotin dissociation rate compared to the wild-type protein. Hence, the analyzed proteins can be sorted according to their biotin-binding affinities (as the biotin dissociation rate decreases, biotin binding strengthens): AVR2 &#x0003c; AVR6 &#x0003c; AVR2(I109K) &#x0003c; AVR4(K109I) &#x0003c; AVR4 &#x0003c; AVD(K111I) &#x0003c; avidin (Figure <xref ref-type="fig" rid="F4">4</xref>).</p><p>The biotin dissociation data, measured at various temperatures, were analysed using the global fit method described elsewhere [<xref ref-type="bibr" rid="B41">41</xref>]. The resulting dissociation rate temperature-dependency model was compared to the one previously measured for avidin [<xref ref-type="bibr" rid="B39">39</xref>]. The analysis revealed a different temperature-dependency for AVR2 in comparison to avidin (Figure <xref ref-type="fig" rid="F4">4B</xref>). The mutation I109K caused a shift in the temperature-dependency of AVR2-biotin dissociation, resulting in a model resembling that determined for AVR6. AVR4 has a similar temperature-dependency of the biotin dissociation rate as avidin, and the K109I mutation did not significantly change the temperature-dependency although it clearly increased the biotin dissociation rate constant (Figure <xref ref-type="fig" rid="F4">4B</xref>). The equivalent mutation K111I in avidin resulted in a nearly two-fold increase in the biotin dissociation rate over a temperature range of 40&#x02013;60&#x000b0;C (Figure <xref ref-type="fig" rid="F4">4B</xref>).</p></sec><sec><title>Differential scanning calorimetry</title><p>The thermostability of avidin, AVR2, AVR4 and AVR6 were measured using DSC analysis (Table <xref ref-type="table" rid="T2">2</xref>). In this analysis, AVR2 showed higher thermostability than avidin. The measured T<sub>m </sub>(91.3&#x000b0;C) was between the values measured previously for avidin (83.5&#x000b0;C) and AVR4 (106.4&#x000b0;C) [<xref ref-type="bibr" rid="B36">36</xref>]. As expected, the thermal stability of AVR2 increased in the presence of biotin (T<sub>m </sub>= 112.5&#x000b0;C), similarly as reported for avidin, AVR4 and streptavidin [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B42">42</xref>]. The I109K mutation significantly stabilised AVR2, resulting in a 6.3&#x000b0;C increase in T<sub>m </sub>as compared to the wild-type protein. The reverse mutation, K109I in AVR4 and K111I in avidin, led to destabilisation of the proteins, resulting in a 1.9&#x000b0;C and 7.0&#x000b0;C decrease in the T<sub>m</sub>, respectively. Interestingly, AVR6 showed slightly higher thermal stability (T<sub>m </sub>= 87.7&#x000b0;C) than avidin (T<sub>m </sub>= 83.5&#x000b0;C) in the absence of biotin, while in its presence the T<sub>m </sub>of AVR6 (114.0&#x000b0;C) was raised significantly but remained lower than that measured for the avidin-biotin complex (T<sub>m </sub>= 117.0&#x000b0;C).</p></sec></sec><sec><title>Discussion</title><p>In the present study, we have used targeted mutagenesis and X-ray crystallography combined with the comparative analysis of thermal stability and ligand-binding kinetics to dissect the functional properties of the chicken avidin protein family. The high-resolution structure of AVR2, a close relative of avidin, provides new insights into the biotin-binding mechanism of the avidins and serves as a new source of knowledge for protein engineering studies, too.</p><p>In order to understand the observed differences in the biotin-binding affinities and thermal stabilities within the avidin protein family, the crystal structures of avidin [<xref ref-type="bibr" rid="B26">26</xref>], AVR2, and AVR4 [<xref ref-type="bibr" rid="B38">38</xref>] were compared, all in complex with D-biotin. Overall, these proteins share high structural similarity and their ligand-binding sites within the eight-strand &#x003b2;-barrel resemble each other. The most distinctive structural differences are found around the terminal carboxylate group and central valeryl segment of D-biotin. In the AVR2 structure, D-biotin is in contact with the L3,4 loop as in the case of avidin [<xref ref-type="bibr" rid="B26">26</xref>] and AVR4 [<xref ref-type="bibr" rid="B38">38</xref>], but also in contact with the side-chain atom of Gln-97 unlike the avidin or AVR4 complexes where leucine is found at the equivalent position. Glutamine is conserved in all of the AVRs except for AVR4 [<xref ref-type="bibr" rid="B35">35</xref>], resides 3.3 &#x000c5; away from D-biotin in the AVR2 structure, and a hydrogen bond may form between Gln-97 and biotin even though the angle is not optimal. In addition to D-biotin, Gln-97 seems to form a hydrogen bond with Ser-73, which exists in two alternative conformations. The presence of Gln-97 in AVR2 probably affects the conformation of nearby Arg-112, which is slightly displaced with respect to the corresponding residue seen in AVR4 and avidin. Then again, the conformation of Arg-112 may be altered due to interactions with the AVR2-specific Ile-109, too. Ile-109 of AVR2 respectively corresponds to Lys-109 and Lys-111 in avidin and AVR4. In AVR2, Ile-109 resides close to Trp-108, which is known to be important for biotin binding [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B30">30</xref>], but the conformation of Trp-108 does not seem to be significantly affected by Ile-109. Yet another sequence difference, whereby Thr-77 of avidin and the corresponding threonine of AVR4 (residue 75 in the AVRs) is substituted to Ser in AVR2 does not appear to disrupt hydrogen bonding to the sulfur atom of D-biotin. However, this substitution enlarges the binding cavity around bound biotin (Figure <xref ref-type="fig" rid="F2">2</xref>) and hence contributes to the lower affinity of AVR2 for biotin. The biotin-binding network is not identical in avidin, AVR2 and AVR4 despite the similar conformation that D-biotin adopts in all of these structures. In general, the polar contacts with D-biotin seem to be much more variable than the hydrophobic ones, which are highly conserved, indicating their important role in the biotin-binding process. In line with this, the importance of hydrophobic residues for biotin-binding of streptavidin has been demonstrated experimentally [<xref ref-type="bibr" rid="B30">30</xref>]. Moreover, the interactions of avidin, AVR2 and AVR4 with the carboxylate group of D-biotin are clearly less conserved than the interactions with the central aliphatic valeryl segment and the bicyclic ring system of the tetrahydrothiophenic and ureido rings buried deeper within the biotin binding pocket [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B43">43</xref>].</p><p>Based on the temperature-dependence of the biotin dissociation rates and relative biotin dissociation rate constants (Figure <xref ref-type="fig" rid="F4">4</xref>), the order of the biotin binding affinities is as follows: AVR2 &#x0003c; AVR6 &#x0003c; AVR4 &#x0003c; avidin. These results are in line with the previous ligand-binding analyses performed for AVRs using an optical biosensor [<xref ref-type="bibr" rid="B35">35</xref>]. Furthermore, the presence of an isoleucine residue at sequence position 109 in AVR2 rather than lysine seems to be the most dominant difference affecting biotin binding in comparison to AVR6. However, this sequence variation does not explain the differences in the biotin-binding properties of AVR2 <italic>versus </italic>AVR4. This was confirmed by analysing the AVR4(K109I) mutant, which showed significantly stronger interactions with biotin when compared to wild-type AVR2. Moreover, the equivalent mutation K111I in avidin affected only slightly the dissociation rate constant of avidin. The temperature-dependency model suggests even slower dissociation rates at low temperatures for the mutant compared to wild-type avidin (Figure <xref ref-type="fig" rid="F4">4B</xref>). The different effects of the Lys&#x02192;Ile mutation on avidin <italic>versus </italic>AVR4 may reflect differences at the L3,4 loop of avidin and AVRs. Although the AVR2-biotin dissociation rate was over 5000-fold higher at 20&#x000b0;C than that of avidin and thus showed significantly lower biotin-binding affinity than avidin, the thermal stability of AVR2 in the absence of biotin is higher (T<sub>m </sub>= 91.3&#x000b0;C) than for avidin (T<sub>m </sub>= 83.5&#x000b0;C). Higher thermal stability is notable and may have a functional role.</p><p>The biological role of AVRs is unclear; avidin is thought to work as a biotin-harvester in chicken egg-white, thus preventing growth of biotin-dependent organisms [<xref ref-type="bibr" rid="B1">1</xref>]. The lower biotin-binding affinity and higher stability of AVR2 raises the question if AVR2 has any biological role similar to avidin. The expression of avidin is induced in chicken during inflammation in various tissues and mRNAs of some AVRs, including AVR2, have been detected during inflammation [<xref ref-type="bibr" rid="B11">11</xref>]. This suggests that AVR2 (and the other AVRs) may play a role in inflammatory reactions.</p><p>The conformation of the L3,4 loop of AVR2 was found to strongly resemble that of AVR4 [<xref ref-type="bibr" rid="B38">38</xref>]. In avidin, this loop is disordered in the absence and ordered in the presence of D-biotin [<xref ref-type="bibr" rid="B25">25</xref>]. In contrast, the L3,4 loop of AVR4 was previously found to be in an nearly identical, fixed conformation both in the absence and presence of D-biotin [<xref ref-type="bibr" rid="B38">38</xref>]. The latter situation seems to be true for all AVR proteins, since the L3,4 loop <italic>per se</italic>, as well as the neighbouring sequences between the &#x003b2;3 and &#x003b2;5 strands, are highly conserved within the AVR family but quite different from avidin [<xref ref-type="bibr" rid="B35">35</xref>]. Recently, this region was transferred to avidin from AVR4 [<xref ref-type="bibr" rid="B39">39</xref>]. The resultant chimeric ChiAVD showed better thermal stability (T<sub>m </sub>= 96.5&#x000b0;C) than avidin (T<sub>m </sub>= 83.5&#x000b0;C) [<xref ref-type="bibr" rid="B39">39</xref>] and, interestingly, the observed stability of AVR2 (T<sub>m </sub>= 91.3&#x000b0;C) and its mutant AVR2(I109K) (T<sub>m </sub>= 97.6&#x000b0;C) was similar to that of ChiAVD. Hence, in addition to the 1&#x02013;3 subunit interface, the region between the &#x003b2;3 and &#x003b2;5 strands of AVR2 is likely to affect the stability of the protein (Figure <xref ref-type="fig" rid="F3">3</xref>). This view is supported by our preliminary results of engineered dual chain avidins suggesting only slightly better stability for the AVR2-type 1&#x02013;3 interface compared to the 1&#x02013;3 interface of avidin (Hyt&#x000f6;nen <italic>et al. </italic>unpublished results).</p><p>The present study provides novel knowledge of the structural characteristics of AVR proteins. Avidin related proteins are considered as an individual branch in the evolutionary tree of avidins in chicken [<xref ref-type="bibr" rid="B44">44</xref>]. Based on the results of the current study (Figure <xref ref-type="fig" rid="F5">5</xref>), AVR2 and AVR6 seem to be functionally closely related to each other, supporting the previous phylogenetic analysis [<xref ref-type="bibr" rid="B44">44</xref>]. It seems that the critical difference, isoleucine at position 109 in AVR2 in comparison to lysine in avidin and the other AVRs, has arisen after the divergence of AVR4 and the rest of AVRs. This sequence difference also explains why AVR2 has the lowest observed biotin-binding affinity among the AVRs. All AVRs have a region between &#x003b2;3 and &#x003b2;5 strands, which is quite different from that in avidin [<xref ref-type="bibr" rid="B35">35</xref>]. In comparison with the other AVRs, this region in AVR4 shares a higher level of similarity with avidin. This likely correlates with the high, avidin-like biotin-affinity of AVR4 <italic>versus </italic>the lower biotin-affinity of the other AVRs [<xref ref-type="bibr" rid="B39">39</xref>].</p><p>Ligand binding to avidin and streptavidin can be considered as an extreme discovery of nature in the sense of affinity and free energy [<xref ref-type="bibr" rid="B45">45</xref>]. The structural complementarity between biotin and its binding site in (strept)avidin is almost perfect, which together with the numerous hydrogen bonds that are formed between (strept)avidin and biotin is the basis for the extraordinary tight binding [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. Thus, it is not surprising to find that a small perturbation in this highly perfected system can reverberate as a major change in the biotin binding kinetics. It is known that the high biotin-binding affinity of (strept)avidin is dominated by extremely slow ligand dissociation rates, especially in the case of avidin.</p></sec><sec><title>Conclusion</title><p>The high-resolution structure of AVR2 combined with the ligand binding data broadens our understanding of the general principles of ligand-binding processes. Furthermore, the structural information can be employed as a basis to create improved tools for biotechnology. This was demonstrated in a previous study, where chimeric forms of avidin and AVR4 showed improved properties compared to the native proteins [<xref ref-type="bibr" rid="B39">39</xref>].</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Production and mutagenesis of proteins</title><p>Proteins were expressed using the Bac-to-Bac baculovirus expression system in Sf9 insect cells in biotin-free media as previously reported [<xref ref-type="bibr" rid="B40">40</xref>]. Bacterial expression in BL-21(AI) (Invitrogen) was also used for protein expression as described in Ref. [<xref ref-type="bibr" rid="B36">36</xref>]. The proteins were isolated using affinity chromatography with an 2-iminobiotin or biotin matrix (Affiland S. A., Belgium) as described earlier [<xref ref-type="bibr" rid="B17">17</xref>]. Biotin was used as the capture ligand for AVR2, AVR2-b, AVR2(I109K) and AVR6-b, and for these proteins elution was achieved using acetic acid. The recombinant proteins investigated in this article are summarised in Table <xref ref-type="table" rid="T1">1</xref>.</p></sec><sec><title>Crystallization and data collection</title><p>Minimal Screen 12 [<xref ref-type="bibr" rid="B46">46</xref>], a sparse matrix protein crystallization screen [<xref ref-type="bibr" rid="B47">47</xref>], was used to search for suitable conditions for crystallization of AVR2-b with the vapor diffusion hanging drop method at 22&#x000b0;C. An orthorhombic crystal with approximate dimensions of 0.15 &#x000d7; 0.1 &#x000d7; 0.1 mm was obtained within three weeks using equal volumes (1 &#x003bc;l) of sample solution containing 0.5 mg/ml protein in 50 mM NaPO<sub>4 </sub>(pH 7.0), 100 mM NaCl and well solution containing 0.1 M Na-citrate (pH 4.6) and 1.5 M NH<sub>4</sub>PO<sub>4</sub>. Before crystallization, the AVR2-b &#x02013; biotin complex was prepared by adding biotin to the protein solution in a molar ratio of 5:1, respectively, followed by incubation at 4&#x000b0;C for 1.5 hours. For data collection, the AVR2-b crystal was cryoprotected with 20% glycerol (v/v) and 2 M lithium sulfate just prior to flash-freezing in a 100 K nitrogen stream (Oxford Cryostream). Diffraction data were collected from a single crystal at the ESRF beam line ID14-1, Grenoble at 100 K using an ADSC Q4R CCD detector. Data were processed with programs of the XDS program package [<xref ref-type="bibr" rid="B48">48</xref>]. Data collection statistics are summarized in Table <xref ref-type="table" rid="T3">3</xref>.</p></sec><sec><title>Structure determination</title><p>The X-ray structure of AVR2-b was solved using the molecular replacement method and programs from the CCP4i suite [<xref ref-type="bibr" rid="B49">49</xref>]. The space group (<italic>P</italic>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>) of the AVR2-b crystal was ascertained by Amore [<xref ref-type="bibr" rid="B50">50</xref>] and molecular replacement was done with Molrep [<xref ref-type="bibr" rid="B51">51</xref>]. A tetramer (biological unit) composed of only main-chain atoms and based on a high resolution X-ray structure of avidin (Airenne, Hyt&#x000f6;nen <italic>et al. </italic>unpublished; [PDB:1VYO]) was used as a trial model. The best solution (correlation coefficient = 0.291) from molecular replacement was selected as the input for automatic model building with ARP/wARP [<xref ref-type="bibr" rid="B52">52</xref>]. After adding side chains separately for each monomer A to H using the guiSIDE mode of ARP/wARP, the model was refined with Refmac5 [<xref ref-type="bibr" rid="B53">53</xref>], and modified and rebuilt with O [<xref ref-type="bibr" rid="B54">54</xref>]. Solvent atoms were added to the model with the automatic procedure of ARP/wARP [<xref ref-type="bibr" rid="B55">55</xref>] and the ligand biotin was built with the ARP/wARP LigandBuild program [<xref ref-type="bibr" rid="B56">56</xref>]. Sulfate ions and glycerol molecules were built either manually in O or with the aid of the program Coot [<xref ref-type="bibr" rid="B57">57</xref>]. The AVR2-b structure was analyzed with the programs PROCHECK [<xref ref-type="bibr" rid="B58">58</xref>] and WHATIF [<xref ref-type="bibr" rid="B59">59</xref>]. Structure determination statistics are summarized in Table <xref ref-type="table" rid="T3">3</xref>. The coordinates and structure factors of AVR2-b have been deposited in the Protein Data Bank with entry code [PDB:1WBI].</p></sec><sec><title>Biotin dissociation analysis</title><p>The dissociation rate constant of AVR2-b, AVR2(I109K), AVR4(K109I), AVR6-b and AVD(K111I)-b for [<sup>3</sup>H]biotin was measured at various temperatures as previously described [<xref ref-type="bibr" rid="B60">60</xref>]. [<sup>3</sup>H]Biotin was purchased from Amersham. The data were analysed by using the global fit approach as shown by Hyre <italic>et al. </italic>[<xref ref-type="bibr" rid="B41">41</xref>], in which the temperature dependence of the dissociation rate constant is modelled by the Eyring equation.</p></sec><sec><title>Differential scanning calorimetry</title><p>The thermal stability of AVR2, AVR2-b, AVR2(I109K), AVR4(K109I), AVR6-b and AVD(K111I) was studied using differential scanning calorimetry (DSC) as previously described [<xref ref-type="bibr" rid="B61">61</xref>]. The melting point of protein unfolding was determined from thermograms measured in a buffer containing 50 mM NaPO<sub>4 </sub>(pH 7.0) and 100 mM NaCl. Proteins were also analysed in the presence of biotin (three-fold molar excess of biotin per protein subunit).</p></sec><sec><title>Size exclusion chromatography</title><p>Gel filtration experiments were performed as described in Ref. [<xref ref-type="bibr" rid="B23">23</xref>] with a Superdex HR 10/30 column using 50 mM NaCO<sub>3 </sub>(pH 11.0), 150 mM NaCl as the liquid phase. The column was calibrated using IgG (158 kDa), BSA (68 kDa) and ovalbumin (44 kDa) as molecular weight standards.</p></sec><sec><title>Mass spectroscopy</title><p>The molecular weight of AVR2-b was measured with a Micromass LCT Electronspray ionization TOF Mass spectrometer essentially as described previously [<xref ref-type="bibr" rid="B37">37</xref>]. Samples were dialysed against water and diluted 1:1 with acetonitrile. The final protein concentration was 7 &#x003bc;M and the pH was adjusted using formic acid (0.2 %). Positive ions were detected using the default parameters (source temperature 100&#x000b0;C, desolvation temperature 120&#x000b0;C, RF lens voltage 750 V, extraction cone voltage 6 V, sample cone voltage 50 V, capillary voltage 3800 V) and the sample was injected at a rate of 20 &#x003bc;l/min.</p></sec><sec><title>Phylogeny inference</title><p>Avidin-related sequences were aligned using MALIGN [<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref>]. One-thousand bootstrap variations [<xref ref-type="bibr" rid="B64">64</xref>] of the alignment were generated using SEQBOOT and distance matrices produced using a structure-based scoring matrix [<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref>]. Trees were produced using NEIGHBOR, and the consensus tree produced using CONSENSE. SEQBOOT, NEIGHBOR and CONSENSE are programs from the PHYLIP package [<xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B66">66</xref>].</p></sec><sec><title>Miscellaneous methods</title><p>The multiple sequence alignment shown in Figure <xref ref-type="fig" rid="F1">1A</xref> was created using the program MALIGN [<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref>] of Bodil [<xref ref-type="bibr" rid="B67">67</xref>] and edited with Corel Draw11. The protein representations in Figure <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref>, <xref ref-type="fig" rid="F3">3</xref> were made with the PyMOL Molecular Graphics System [<xref ref-type="bibr" rid="B68">68</xref>] and edited with the programs Gimp and/or Corel Draw11. Cavities were calculated with Surfnet [<xref ref-type="bibr" rid="B69">69</xref>] using 1.4 &#x000c5; and 3.0 &#x000c5; radii for minimum and maximum gap spheres, respectively. The electron density map shown in Figure <xref ref-type="fig" rid="F1">1C</xref> and <xref ref-type="fig" rid="F1">1D</xref> was calculated with programs of the CCP4i suite.</p></sec></sec><sec><title>Authors' contributions</title><p>The biochemical studies of AVD and AVRs were mainly carried out by VPH and JAEM in the group of Prof. MSK at the University of Jyv&#x000e4;skyl&#x000e4; and Tampere. JAEM performed also the mutagenesis analyses. HK had an important role in crystallizing the AVR2, whereas KKH and TKMN carried out the DSC analyses. JH had a major role in the expression and purification of the studied AVD and AVRs. TK performed most of the <sup>3</sup>H-biotin dissociation analyses and MSJ made the phylogenetic inference analysis. The structural analysis of AVR2 was made mainly by TTA in the Structural Bioinformatics Laboratory led by the group leaders MSJ and TAS.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We would like to thank Irene Helkala and Eila Korhonen for excellent technical assistance, Professor J. Peter Slotte for access to the calorimetry facilities and Professor Kari Rissanen for access to the mass spectrometry laboratory. We thank Drs. David Hyre and Olli H. Laitinen for helpful discussions. This study was supported by the ISB (National Graduate School in Informational and Structural Biology (V.P.H, H.K.)), grants from the Academy of Finland, the Sigrid Jus&#x000e9;lius Foundation, and the Foundation of &#x000c5;bo Akademi. This work was supported by ARK Therapeutics Oy, Kuopio, Finland. We acknowledge the European Synchrotron Radiation Facility for provision of synchrotron radiation facilities and we would like to thank the staff for assistance in using beamline ID14-1.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>NM</given-names></name></person-group><article-title>Avidin</article-title><source>Adv Prot Chem</source><year>1975</year><volume>29</volume><fpage>85</fpage><lpage>133</lpage></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>NM</given-names></name></person-group><article-title>Avidin and streptavidin</article-title><source>Method Enzymol</source><year>1990</year><volume>184</volume><fpage>51</fpage><lpage>67</lpage></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name></person-group><article-title>Introduction to avidin-biotin technology</article-title><source>Method Enzymol</source><year>1990</year><volume>184</volume><fpage>5</fpage><lpage>13</lpage></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name></person-group><article-title>Foreword and introduction to the book (strept)avidin-biotin system</article-title><source>Biomol Eng</source><year>1999</year><volume>16</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10796978</pub-id><pub-id pub-id-type="doi">10.1016/S1050-3862(99)00032-7</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hertz</surname><given-names>R</given-names></name><name><surname>Sebrell</surname><given-names>WH</given-names></name></person-group><article-title>Occurrence of avidin in the oviduct and secretions of the genital tract of several species</article-title><source>Science</source><year>1942</year><volume>96</volume><fpage>257</fpage></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>PDBMH</given-names></name></person-group><article-title>Distribution of avidin</article-title><source>Life Sci</source><year>1962</year><volume>11</volume><fpage>621</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1016/0024-3205(62)90094-2</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korpela</surname><given-names>JK</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name><name><surname>Elo</surname><given-names>HA</given-names></name><name><surname>Tuohimaa</surname><given-names>PJ</given-names></name></person-group><article-title>Biotin-binding proteins in eggs of oviparous vertebrates</article-title><source>Experientia</source><year>1981</year><volume>37</volume><fpage>1065</fpage><lpage>1066</lpage><pub-id pub-id-type="pmid">7308390</pub-id><pub-id pub-id-type="doi">10.1007/BF02085010</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kein&#x000e4;nen</surname><given-names>RA</given-names></name><name><surname>Laukkanen</surname><given-names>ML</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Molecular cloning of three structurally related genes for chicken avidin</article-title><source>J Steroid Biochem</source><year>1988</year><volume>30</volume><fpage>17</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">2838690</pub-id><pub-id pub-id-type="doi">10.1016/0022-4731(88)90071-4</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kein&#x000e4;nen</surname><given-names>RA</given-names></name><name><surname>Wall&#x000e9;n</surname><given-names>MJ</given-names></name><name><surname>Kristo</surname><given-names>PA</given-names></name><name><surname>Laukkanen</surname><given-names>MO</given-names></name><name><surname>Toimela</surname><given-names>TA</given-names></name><name><surname>Helenius</surname><given-names>MA</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Molecular cloning and nucleotide sequence of chicken avidin-related genes 1-5</article-title><source>Eur J Biochem</source><year>1994</year><volume>220</volume><fpage>615</fpage><lpage>621</lpage><pub-id pub-id-type="pmid">8125122</pub-id><pub-id pub-id-type="doi">10.1111/j.1432-1033.1994.tb18663.x</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahlroth</surname><given-names>MK</given-names></name><name><surname>Kola</surname><given-names>EH</given-names></name><name><surname>Ewald</surname><given-names>D</given-names></name><name><surname>Masabanda</surname><given-names>J</given-names></name><name><surname>Sazanov</surname><given-names>A</given-names></name><name><surname>Fries</surname><given-names>R</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Characterization and chromosomal localization of the chicken avidin gene family</article-title><source>Anim Genet</source><year>2000</year><volume>31</volume><fpage>367</fpage><lpage>375</lpage><pub-id pub-id-type="pmid">11167523</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2052.2000.00681.x</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kunnas</surname><given-names>TA</given-names></name><name><surname>Wall&#x000e9;n</surname><given-names>MJ</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Induction of chicken avidin and related mRNAs after bacterial infection</article-title><source>Biochim Biophys Acta</source><year>1993</year><volume>1216</volume><fpage>441</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">8268225</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niskanen</surname><given-names>EA</given-names></name><name><surname>Hyt&#x000f6;nen</surname><given-names>VP</given-names></name><name><surname>Grapputo</surname><given-names>A</given-names></name><name><surname>Nordlund</surname><given-names>HR</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name><name><surname>Laitinen</surname><given-names>OH</given-names></name></person-group><article-title>Chicken genome analysis reveals novel genes encoding biotin-binding proteins related to avidin family</article-title><source>BMC Genomics</source><year>2005</year><volume>6</volume><fpage>41</fpage><pub-id pub-id-type="pmid">15777476</pub-id><pub-id pub-id-type="doi">10.1186/1471-2164-6-41</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahlroth</surname><given-names>MK</given-names></name><name><surname>Ahlroth</surname><given-names>P</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Copy-number fluctuation by unequal crossing-over in the chicken avidin gene family</article-title><source>Biochem Bioph Res Co</source><year>2001</year><volume>288</volume><fpage>400</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.5760</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wall&#x000e9;n</surname><given-names>MJ</given-names></name><name><surname>Laukkanen</surname><given-names>MO</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Cloning and sequencing of the chicken egg-white avidin-encoding gene and its relationship with the avidin-related genes Avr1-Avr5</article-title><source>Gene</source><year>1995</year><volume>161</volume><fpage>205</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">7665080</pub-id><pub-id pub-id-type="doi">10.1016/0378-1119(95)00187-B</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nardone</surname><given-names>E</given-names></name><name><surname>Rosano</surname><given-names>C</given-names></name><name><surname>Santambrogio</surname><given-names>P</given-names></name><name><surname>Curnis</surname><given-names>F</given-names></name><name><surname>Corti</surname><given-names>A</given-names></name><name><surname>Magni</surname><given-names>F</given-names></name><name><surname>Siccardi</surname><given-names>AG</given-names></name><name><surname>Paganelli</surname><given-names>G</given-names></name><name><surname>Losso</surname><given-names>R</given-names></name><name><surname>Apreda</surname><given-names>B</given-names></name><name><surname>Bolognesi</surname><given-names>M</given-names></name><name><surname>Sidoli</surname><given-names>A</given-names></name><name><surname>Arosio</surname><given-names>P</given-names></name></person-group><article-title>Biochemical characterization and crystal structure of a recombinant hen avidin and its acidic mutant expressed in Escherichia coli</article-title><source>Eur J Biochem</source><year>1998</year><volume>256</volume><fpage>453</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">9760187</pub-id><pub-id pub-id-type="doi">10.1046/j.1432-1327.1998.2560453.x</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marttila</surname><given-names>AT</given-names></name><name><surname>Airenne</surname><given-names>KJ</given-names></name><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Kulik</surname><given-names>T</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Engineering of chicken avidin: a progressive series of reduced charge mutants</article-title><source>FEBS Lett</source><year>1998</year><volume>441</volume><fpage>313</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">9883906</pub-id><pub-id pub-id-type="doi">10.1016/S0014-5793(98)01570-1</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Airenne</surname><given-names>KJ</given-names></name><name><surname>Marttila</surname><given-names>AT</given-names></name><name><surname>Kulik</surname><given-names>T</given-names></name><name><surname>Porkka</surname><given-names>E</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Mutation of a critical tryptophan to lysine in avidin or streptavidin may explain why sea urchin fibropellin adopts an avidin-like domain</article-title><source>FEBS Lett</source><year>1999</year><volume>461</volume><fpage>52</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">10561495</pub-id><pub-id pub-id-type="doi">10.1016/S0014-5793(99)01423-4</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marttila</surname><given-names>AT</given-names></name><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Airenne</surname><given-names>KJ</given-names></name><name><surname>Kulik</surname><given-names>T</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Recombinant NeutraLite avidin: a non-glycosylated, acidic mutant of chicken avidin that exhibits high affinity for biotin and low non-specific binding properties</article-title><source>FEBS Lett</source><year>2000</year><volume>467</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">10664451</pub-id><pub-id pub-id-type="doi">10.1016/S0014-5793(00)01119-4</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Marttila</surname><given-names>AT</given-names></name><name><surname>Airenne</surname><given-names>KJ</given-names></name><name><surname>Kulik</surname><given-names>T</given-names></name><name><surname>Livnah</surname><given-names>O</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Biotin induces tetramerization of a recombinant monomeric avidin. A model for protein-protein interactions</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>8219</fpage><lpage>8224</lpage><pub-id pub-id-type="pmid">11076945</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M007930200</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Nordlund</surname><given-names>HR</given-names></name><name><surname>Hyt&#x000f6;nen</surname><given-names>VP</given-names></name><name><surname>Uotila</surname><given-names>ST</given-names></name><name><surname>Marttila</surname><given-names>AT</given-names></name><name><surname>Savolainen</surname><given-names>J</given-names></name><name><surname>Airenne</surname><given-names>KJ</given-names></name><name><surname>Livnah</surname><given-names>O</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Rational design of an active avidin monomer</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>4010</fpage><lpage>4014</lpage><pub-id pub-id-type="pmid">12458212</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M205844200</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marttila</surname><given-names>AT</given-names></name><name><surname>Hyt&#x000f6;nen</surname><given-names>VP</given-names></name><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Mutation of the important Tyr-33 residue of chicken avidin: functional and structural consequences</article-title><source>Biochem J</source><year>2003</year><volume>369</volume><fpage>249</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">12358604</pub-id><pub-id pub-id-type="doi">10.1042/BJ20020886</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nordlund</surname><given-names>HR</given-names></name><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Uotila</surname><given-names>ST</given-names></name><name><surname>Nyholm</surname><given-names>T</given-names></name><name><surname>Hyt&#x000f6;nen</surname><given-names>VP</given-names></name><name><surname>Slotte</surname><given-names>JP</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Enhancing the thermal stability of avidin. Introduction of disulfide bridges between subunit interfaces</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>2479</fpage><lpage>2483</lpage><pub-id pub-id-type="pmid">12446662</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M210721200</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nordlund</surname><given-names>HR</given-names></name><name><surname>Hyt&#x000f6;nen</surname><given-names>VP</given-names></name><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Uotila</surname><given-names>ST</given-names></name><name><surname>Niskanen</surname><given-names>EA</given-names></name><name><surname>Savolainen</surname><given-names>J</given-names></name><name><surname>Porkka</surname><given-names>E</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Introduction of histidine residues into avidin subunit interfaces allows pH-dependent regulation of quaternary structure and biotin binding</article-title><source>FEBS Lett</source><year>2003</year><volume>555</volume><fpage>449</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">14675754</pub-id><pub-id pub-id-type="doi">10.1016/S0014-5793(03)01302-4</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nordlund</surname><given-names>HR</given-names></name><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Hyt&#x000f6;nen</surname><given-names>VP</given-names></name><name><surname>Uotila</surname><given-names>ST</given-names></name><name><surname>Porkka</surname><given-names>E</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Construction of a dual chain pseudotetrameric chicken avidin by combining two circularly permuted avidins</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>36715</fpage><lpage>36719</lpage><pub-id pub-id-type="pmid">15131113</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M403496200</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livnah</surname><given-names>O</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Sussman</surname><given-names>JL</given-names></name></person-group><article-title>Three-dimensional structures of avidin and the avidin-biotin complex</article-title><source>Proc Natl Acad Sci USA</source><year>1993</year><volume>90</volume><fpage>5076</fpage><lpage>5080</lpage><pub-id pub-id-type="pmid">8506353</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pugliese</surname><given-names>L</given-names></name><name><surname>Coda</surname><given-names>A</given-names></name><name><surname>Malcovati</surname><given-names>M</given-names></name><name><surname>Bolognesi</surname><given-names>M</given-names></name></person-group><article-title>Three-dimensional structure of the tetragonal crystal form of egg-white avidin in its functional complex with biotin at 2.7 &#x000c5; resolution</article-title><source>J Mol Biol</source><year>1993</year><volume>231</volume><fpage>698</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">8515446</pub-id><pub-id pub-id-type="doi">10.1006/jmbi.1993.1321</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Argarana</surname><given-names>CE</given-names></name><name><surname>Kuntz</surname><given-names>ID</given-names></name><name><surname>Birken</surname><given-names>S</given-names></name><name><surname>Axel</surname><given-names>R</given-names></name><name><surname>Cantor</surname><given-names>CR</given-names></name></person-group><article-title>Molecular cloning and nucleotide sequence of the streptavidin gene</article-title><source>Nucleic Acids Res</source><year>1986</year><volume>14</volume><fpage>1871</fpage><lpage>1882</lpage><pub-id pub-id-type="pmid">3951999</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>PC</given-names></name><name><surname>Ohlendorf</surname><given-names>DH</given-names></name><name><surname>Wendoloski</surname><given-names>JJ</given-names></name><name><surname>Salemme</surname><given-names>FR</given-names></name></person-group><article-title>Structural origins of high-affinity biotin binding to streptavidin</article-title><source>Science</source><year>1989</year><volume>243</volume><fpage>85</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">2911722</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sano</surname><given-names>T</given-names></name><name><surname>Pandori</surname><given-names>MW</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Smith</surname><given-names>CL</given-names></name><name><surname>Cantor</surname><given-names>CR</given-names></name></person-group><article-title>Recombinant core streptavidins. A minimum-sized core streptavidin has enhanced structural stability and higher accessibility to biotinylated macromolecules</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>28204</fpage><lpage>28209</lpage><pub-id pub-id-type="pmid">7499314</pub-id><pub-id pub-id-type="doi">10.1074/jbc.270.47.28204</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chilkoti</surname><given-names>A</given-names></name><name><surname>Tan</surname><given-names>PH</given-names></name><name><surname>Stayton</surname><given-names>PS</given-names></name></person-group><article-title>Site-directed mutagenesis studies of the high-affinity streptavidin-biotin complex: contributions of tryptophan residues 79, 108, and 120</article-title><source>Proc Natl Acad Sci USA</source><year>1995</year><volume>92</volume><fpage>1754</fpage><lpage>1758</lpage><pub-id pub-id-type="pmid">7878054</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reznik</surname><given-names>GO</given-names></name><name><surname>Vajda</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>CL</given-names></name><name><surname>Cantor</surname><given-names>CR</given-names></name><name><surname>Sano</surname><given-names>T</given-names></name></person-group><article-title>Streptavidins with intersubunit crosslinks have enhanced stability</article-title><source>Nat Biotechnol</source><year>1996</year><volume>14</volume><fpage>1007</fpage><lpage>1011</lpage><pub-id pub-id-type="pmid">9631041</pub-id><pub-id pub-id-type="doi">10.1038/nbt0896-1007</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stayton</surname><given-names>PS</given-names></name><name><surname>Nelson</surname><given-names>KE</given-names></name><name><surname>McDevitt</surname><given-names>TC</given-names></name><name><surname>Bulmus</surname><given-names>V</given-names></name><name><surname>Shimoboji</surname><given-names>T</given-names></name><name><surname>Ding</surname><given-names>Z</given-names></name><name><surname>Hoffman</surname><given-names>AS</given-names></name></person-group><article-title>Smart and biofunctional streptavidin</article-title><source>Biomol Eng</source><year>1999</year><volume>16</volume><fpage>93</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">10796990</pub-id><pub-id pub-id-type="doi">10.1016/S1050-3862(99)00043-1</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qureshi</surname><given-names>MH</given-names></name><name><surname>Yeung</surname><given-names>JC</given-names></name><name><surname>Wu</surname><given-names>SC</given-names></name><name><surname>Wong</surname><given-names>SL</given-names></name></person-group><article-title>Development and characterization of a series of soluble tetrameric and monomeric streptavidin muteins with differential biotin binding affinities</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>46422</fpage><lpage>46428</lpage><pub-id pub-id-type="pmid">11584006</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M107398200</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pazy</surname><given-names>Y</given-names></name><name><surname>Raboy</surname><given-names>B</given-names></name><name><surname>Matto</surname><given-names>M</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Livnah</surname><given-names>O</given-names></name></person-group><article-title>Structure-based rational design of streptavidin mutants with pseudo-catalytic activity</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>7131</fpage><lpage>7134</lpage><pub-id pub-id-type="pmid">12493758</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M209983200</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Hyt&#x000f6;nen</surname><given-names>VP</given-names></name><name><surname>Ahlroth</surname><given-names>MK</given-names></name><name><surname>Pentik&#x000e4;inen</surname><given-names>OT</given-names></name><name><surname>Gallagher</surname><given-names>C</given-names></name><name><surname>Nordlund</surname><given-names>HR</given-names></name><name><surname>Ovod</surname><given-names>V</given-names></name><name><surname>Marttila</surname><given-names>AT</given-names></name><name><surname>Porkka</surname><given-names>E</given-names></name><name><surname>Heino</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>MS</given-names></name><name><surname>Airenne</surname><given-names>KJ</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Chicken avidin-related proteins show altered biotin-binding and physico-chemical properties as compared with avidin</article-title><source>Biochem J</source><year>2002</year><volume>363</volume><fpage>609</fpage><lpage>617</lpage><pub-id pub-id-type="pmid">11964162</pub-id><pub-id pub-id-type="doi">10.1042/0264-6021:3630609</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hyt&#x000f6;nen</surname><given-names>VP</given-names></name><name><surname>Nyholm</surname><given-names>TK</given-names></name><name><surname>Pentik&#x000e4;inen</surname><given-names>OT</given-names></name><name><surname>Vaarno</surname><given-names>J</given-names></name><name><surname>Porkka</surname><given-names>EJ</given-names></name><name><surname>Nordlund</surname><given-names>HR</given-names></name><name><surname>Johnson</surname><given-names>MS</given-names></name><name><surname>Slotte</surname><given-names>JP</given-names></name><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Chicken Avidin-related Protein 4/5 Shows Superior Thermal Stability when Compared with Avidin while Retaining High Affinity to Biotin</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>9337</fpage><lpage>9343</lpage><pub-id pub-id-type="pmid">14660583</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M310989200</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hyt&#x000f6;nen</surname><given-names>VP</given-names></name><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Airenne</surname><given-names>TT</given-names></name><name><surname>Kidron</surname><given-names>H</given-names></name><name><surname>Meltola</surname><given-names>NJ</given-names></name><name><surname>Porkka</surname><given-names>E</given-names></name><name><surname>H&#x000f6;rh&#x000e4;</surname><given-names>J</given-names></name><name><surname>Paldanius</surname><given-names>T</given-names></name><name><surname>M&#x000e4;&#x000e4;tt&#x000e4;</surname><given-names>JA</given-names></name><name><surname>Nordlund</surname><given-names>HR</given-names></name><name><surname>Johnson</surname><given-names>MS</given-names></name><name><surname>Salminen</surname><given-names>TA</given-names></name><name><surname>Airenne</surname><given-names>KJ</given-names></name><name><surname>Yl&#x000e4;-Herttuala</surname><given-names>S</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Efficient production of active chicken avidin using a bacterial signal peptide in Escherichia coli</article-title><source>Biochem J</source><year>2004</year><volume>384</volume><fpage>385</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">15324300</pub-id><pub-id pub-id-type="doi">10.1042/BJ20041114</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg-Domovich</surname><given-names>Y</given-names></name><name><surname>Hyt&#x000f6;nen</surname><given-names>VP</given-names></name><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name><name><surname>Livnah</surname><given-names>O</given-names></name></person-group><article-title>High-resolution crystal structure of an avidin-related protein: insight into high-affinity biotin binding and protein stability</article-title><source>Acta Crystallogr D</source><year>2005</year><volume>61</volume><fpage>528</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">15858262</pub-id><pub-id pub-id-type="doi">10.1107/S0907444905003914</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hyt&#x000f6;nen</surname><given-names>VP</given-names></name><name><surname>M&#x000e4;&#x000e4;tt&#x000e4;</surname><given-names>JA</given-names></name><name><surname>Nyholm</surname><given-names>TK</given-names></name><name><surname>Livnah</surname><given-names>O</given-names></name><name><surname>Eisenberg-Domovich</surname><given-names>Y</given-names></name><name><surname>Hyre</surname><given-names>D</given-names></name><name><surname>Nordlund</surname><given-names>HR</given-names></name><name><surname>H&#x000f6;rh&#x000e4;</surname><given-names>J</given-names></name><name><surname>Niskanen</surname><given-names>EA</given-names></name><name><surname>Paldanius</surname><given-names>T</given-names></name><name><surname>Kulomaa</surname><given-names>T</given-names></name><name><surname>Porkka</surname><given-names>EJ</given-names></name><name><surname>Stayton</surname><given-names>PS</given-names></name><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Design and construction of highly stable, protease-resistant chimeric avidins</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>10228</fpage><lpage>10233</lpage><pub-id pub-id-type="pmid">15649900</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M414196200</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Airenne</surname><given-names>KJ</given-names></name><name><surname>Oker-Blom</surname><given-names>C</given-names></name><name><surname>Marjom&#x000e4;ki</surname><given-names>VS</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Production of biologically active recombinant avidin in baculovirus-infected insect cells</article-title><source>Prot Exp Pur</source><year>1997</year><volume>9</volume><fpage>100</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1006/prep.1996.0660</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hyre</surname><given-names>DE</given-names></name><name><surname>Le Trong</surname><given-names>I</given-names></name><name><surname>Freitag</surname><given-names>S</given-names></name><name><surname>Stenkamp</surname><given-names>RE</given-names></name><name><surname>Stayton</surname><given-names>PS</given-names></name></person-group><article-title>Ser45 plays an important role in managing both the equilibrium and transition state energetics of the streptavidin-biotin system</article-title><source>Protein Sci</source><year>2000</year><volume>9</volume><fpage>878</fpage><lpage>885</lpage><pub-id pub-id-type="pmid">10850797</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>M</given-names></name><name><surname>Argarana</surname><given-names>CE</given-names></name><name><surname>Fidelio</surname><given-names>GD</given-names></name></person-group><article-title>Extremely high thermal stability of streptavidin and avidin upon biotin binding</article-title><source>Biomol Eng</source><year>1999</year><volume>16</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">10796986</pub-id><pub-id pub-id-type="doi">10.1016/S1050-3862(99)00041-8</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livnah</surname><given-names>O</given-names></name><name><surname>Bayer</surname><given-names>A</given-names></name><name><surname>Wilchek</surname><given-names>M</given-names></name><name><surname>Sussman</surname><given-names>JL</given-names></name></person-group><article-title>The structure of the complex between avidin and the dye, 2-(4'-hydroxyazobenzene) benzoic acid (HABA)</article-title><source>FEBS</source><year>1993</year><volume>328</volume><fpage>165</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(93)80986-5</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahlroth</surname><given-names>MK</given-names></name><name><surname>Grapputo</surname><given-names>A</given-names></name><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Sequence features and evolutionary mechanisms in the chicken avidin gene family</article-title><source>Biochem Bioph Res Co</source><year>2001</year><volume>285</volume><fpage>734</fpage><lpage>741</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.5163</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuntz</surname><given-names>ID</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Sharp</surname><given-names>KA</given-names></name><name><surname>Kollman</surname><given-names>PA</given-names></name></person-group><article-title>The maximal affinity of ligands</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>9997</fpage><lpage>10002</lpage><pub-id pub-id-type="pmid">10468550</pub-id><pub-id pub-id-type="doi">10.1073/pnas.96.18.9997</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kimber</surname><given-names>MS</given-names></name><name><surname>Vallee</surname><given-names>F</given-names></name><name><surname>Houston</surname><given-names>S</given-names></name><name><surname>Necakov</surname><given-names>A</given-names></name><name><surname>Skarina</surname><given-names>T</given-names></name><name><surname>Evdokimova</surname><given-names>E</given-names></name><name><surname>Beasley</surname><given-names>S</given-names></name><name><surname>Christendat</surname><given-names>D</given-names></name><name><surname>Savchenko</surname><given-names>A</given-names></name><name><surname>Arrowsmith</surname><given-names>CH</given-names></name><name><surname>Vedadi</surname><given-names>M</given-names></name><name><surname>Gerstein</surname><given-names>M</given-names></name><name><surname>Edwards</surname><given-names>AM</given-names></name></person-group><article-title>Data mining crystallization databases: knowledge-based approaches to optimize protein crystal screens</article-title><source>Proteins</source><year>2003</year><volume>51</volume><fpage>562</fpage><lpage>568</lpage><pub-id pub-id-type="pmid">12784215</pub-id><pub-id pub-id-type="doi">10.1002/prot.10340</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jancarik</surname><given-names>J</given-names></name><name><surname>Scott</surname><given-names>WG</given-names></name><name><surname>Milligan</surname><given-names>DL</given-names></name><name><surname>Koshland</surname><given-names>DEJ</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name></person-group><article-title>Crystallization and preliminary X-ray diffraction study of the ligand-binding domain of the bacterial chemotaxis-mediating aspartate receptor of Salmonella typhimurium</article-title><source>J Mol Biol</source><year>1991</year><volume>221</volume><fpage>31</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">1656050</pub-id><pub-id pub-id-type="doi">10.1016/0022-2836(91)80198-4</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kabsch</surname><given-names>W</given-names></name></person-group><article-title>Automatic Processing of Rotation Diffraction Data from Crystals of Initially Unknown Symmetry and Cell Constants</article-title><source>J Appl Crystallogr</source><year>1993</year><volume>26</volume><fpage>795</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1107/S0021889893005588</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collaborative computational project number 4</surname><given-names/></name></person-group><article-title>The CCP4 suite: programs for protein crystallography</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>1994</year><volume>50</volume><fpage>760</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">15299374</pub-id><pub-id pub-id-type="doi">10.1107/S0907444994003112</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Navaza</surname><given-names>J</given-names></name></person-group><article-title>Amore - an automated package for molecular replacement</article-title><source>Acta Crystallogr A</source><year>1994</year><volume>50</volume><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1107/S0108767393007597</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vagin</surname><given-names>A</given-names></name><name><surname>Teplyakov</surname><given-names>A</given-names></name></person-group><article-title>MOLREP: an automated program for molecular replacement</article-title><source>J Appl Crystallogr</source><year>1997</year><volume>30</volume><fpage>1022</fpage><lpage>1025</lpage><pub-id pub-id-type="doi">10.1107/S0021889897006766</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perrakis</surname><given-names>A</given-names></name><name><surname>Antoniadou-Vyza</surname><given-names>E</given-names></name><name><surname>Tsitsa</surname><given-names>P</given-names></name><name><surname>Lamzin</surname><given-names>VS</given-names></name><name><surname>Wilson</surname><given-names>KS</given-names></name><name><surname>Hamodrakas</surname><given-names>SJ</given-names></name></person-group><article-title>Molecular, crystal and solution structure of a beta-cyclodextrin complex with the bromide salt of 2-(3-dimethylaminopropyl)tricyclo[3.3.1.1(3,7)]decan-2-ol, a potent antimicrobial drug</article-title><source>Carbohydr Res</source><year>1999</year><volume>317</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">10498440</pub-id><pub-id pub-id-type="doi">10.1016/S0008-6215(99)00021-X</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murshudov</surname><given-names>GN</given-names></name><name><surname>Vagin</surname><given-names>AA</given-names></name><name><surname>Dodson</surname><given-names>EJ</given-names></name></person-group><article-title>Refinement of macromolecular structures by the maximum-likelihood method</article-title><source>Acta Crystallogr D</source><year>1997</year><volume>53</volume><fpage>240</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">15299926</pub-id><pub-id pub-id-type="doi">10.1107/S0907444996012255</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>TA</given-names></name><name><surname>Zou</surname><given-names>JY</given-names></name><name><surname>Cowan</surname><given-names>SW</given-names></name><collab>Kjeldgaard</collab></person-group><article-title>Improved methods for building protein models in electron density maps and the location of errors in these models</article-title><source>Acta Crystallogr A</source><year>1991</year><volume>47</volume><fpage>110</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">2025413</pub-id><pub-id pub-id-type="doi">10.1107/S0108767390010224</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lamzin</surname><given-names>VS</given-names></name></person-group><article-title>Automated refinement of protein models</article-title><source>Acta Crystallogr D</source><year>1993</year><volume>49</volume><fpage>129</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">15299554</pub-id><pub-id pub-id-type="doi">10.1107/S0907444992008886</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zwart</surname><given-names>PH</given-names></name><name><surname>Langer</surname><given-names>GG</given-names></name><name><surname>Lamzin</surname><given-names>VS</given-names></name></person-group><article-title>Modelling bound ligands in protein crystal structures</article-title><source>Acta Crystallogr D</source><year>2004</year><volume>60</volume><fpage>2230</fpage><lpage>2239</lpage><pub-id pub-id-type="pmid">15572776</pub-id><pub-id pub-id-type="doi">10.1107/S0907444904012995</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><article-title>Coot: model-building tools for molecular graphics</article-title><source>Acta Crystallogr D</source><year>2004</year><volume>60</volume><fpage>2126</fpage><lpage>2132</lpage><pub-id pub-id-type="pmid">15572765</pub-id><pub-id pub-id-type="doi">10.1107/S0907444904019158</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laskowski</surname><given-names>RA</given-names></name><name><surname>Macarthur</surname><given-names>MW</given-names></name><name><surname>Moss</surname><given-names>DS</given-names></name><name><surname>Thornton</surname><given-names>JM</given-names></name></person-group><article-title>Procheck - a program to check the stereochemical quality of protein structures</article-title><source>J Appl Crystallogr</source><year>1993</year><volume>26</volume><fpage>283</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1107/S0021889892009944</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vriend</surname><given-names>G</given-names></name></person-group><article-title>WHAT IF: a molecular modeling and drug design program</article-title><source>J Mol Graph</source><year>1990</year><volume>8</volume><fpage>52</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">2268628</pub-id><pub-id pub-id-type="doi">10.1016/0263-7855(90)80070-V</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klumb</surname><given-names>LA</given-names></name><name><surname>Chu</surname><given-names>V</given-names></name><name><surname>Stayton</surname><given-names>PS</given-names></name></person-group><article-title>Energetic roles of hydrogen bonds at the ureido oxygen binding pocket in the streptavidin-biotin complex</article-title><source>Biochemistry</source><year>1998</year><volume>37</volume><fpage>7657</fpage><lpage>7663</lpage><pub-id pub-id-type="pmid">9601024</pub-id><pub-id pub-id-type="doi">10.1021/bi9803123</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hyt&#x000f6;nen</surname><given-names>VP</given-names></name><name><surname>Laitinen</surname><given-names>OH</given-names></name><name><surname>Grapputo</surname><given-names>A</given-names></name><name><surname>Kettunen</surname><given-names>A</given-names></name><name><surname>Savolainen</surname><given-names>J</given-names></name><name><surname>Kalkkinen</surname><given-names>N</given-names></name><name><surname>Marttila</surname><given-names>AT</given-names></name><name><surname>Nordlund</surname><given-names>HR</given-names></name><name><surname>Nyholm</surname><given-names>TK</given-names></name><name><surname>Paganelli</surname><given-names>G</given-names></name><name><surname>Kulomaa</surname><given-names>MS</given-names></name></person-group><article-title>Characterization of poultry egg-white avidins and their potential as a tool in pretargeting cancer treatment</article-title><source>Biochem J</source><year>2003</year><volume>372</volume><fpage>219</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">12558501</pub-id><pub-id pub-id-type="doi">10.1042/BJ20021531</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>MS</given-names></name><name><surname>Overington</surname><given-names>JP</given-names></name></person-group><article-title>A structural basis for sequence comparisons. An evaluation of scoring methodologies</article-title><source>J Mol Biol</source><year>1993</year><volume>233</volume><fpage>716</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">8411177</pub-id><pub-id pub-id-type="doi">10.1006/jmbi.1993.1548</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>MS</given-names></name><name><surname>May</surname><given-names>AC</given-names></name><name><surname>Rodionov</surname><given-names>MA</given-names></name><name><surname>Overington</surname><given-names>JP</given-names></name></person-group><article-title>Discrimination of common protein folds: application of protein structure to sequence/structure comparisons</article-title><source>Method Enzymol</source><year>1996</year><volume>266</volume><fpage>575</fpage><lpage>598</lpage></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Felsenstein</surname><given-names>J</given-names></name></person-group><article-title>Confidence limits on phylogenies: an approach using the bootstrap</article-title><source>Evolution</source><year>1985</year><volume>39</volume><fpage>783</fpage><lpage>791</lpage></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Felsenstein</surname><given-names>J</given-names></name></person-group><article-title>PHYLIP -- Phylogeny Inference Package (Version 3.2).</article-title><source>Cladistics</source><year>1989</year><volume>5</volume><fpage>164</fpage><lpage>166</lpage></citation></ref><ref id="B66"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Felsenstein</surname><given-names>J</given-names></name></person-group><source>PHYLIP (Phylogeny Inference Package) version 3.5c. Distributed by the author.</source><year>1993</year><publisher-name>Seattle, Department of Genetics, University of Washington</publisher-name></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lehtonen</surname><given-names>JV</given-names></name><name><surname>Still</surname><given-names>DJ</given-names></name><name><surname>Rantanen</surname><given-names>VV</given-names></name><name><surname>Ekholm</surname><given-names>J</given-names></name><name><surname>Bj&#x000f6;rklund</surname><given-names>D</given-names></name><name><surname>Iftikhar</surname><given-names>Z</given-names></name><name><surname>Huhtala</surname><given-names>M</given-names></name><name><surname>Repo</surname><given-names>S</given-names></name><name><surname>Jussila</surname><given-names>A</given-names></name><name><surname>Jaakkola</surname><given-names>J</given-names></name><name><surname>Pentikainen</surname><given-names>OT</given-names></name><name><surname>Nyr&#x000f6;nen</surname><given-names>T</given-names></name><name><surname>Salminen</surname><given-names>TA</given-names></name><name><surname>Gyllenberg</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name></person-group><article-title>BODIL: a molecular modeling environment for structure-function analysis and drug design.</article-title><source>J Comput Aided Mol Des</source><year>2004</year><volume>18</volume><fpage>401</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">15663001</pub-id><pub-id pub-id-type="doi">10.1007/s10822-004-3752-4</pub-id></citation></ref><ref id="B68"><citation citation-type="book"><person-group person-group-type="author"><name><surname>DeLano</surname><given-names>WL</given-names></name></person-group><source>The PyMOL Molecular Graphics System</source><year>2002</year><publisher-name>, DeLano Scientific, San Carlos, CA, USA.</publisher-name><ext-link ext-link-type="uri" xlink:href="http://pymol.sourceforge.net/"/></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laskowski</surname><given-names>RA</given-names></name></person-group><article-title>SURFNET: a program for visualizing molecular surfaces, cavities, and intermolecular interactions</article-title><source>J Mol Graph</source><year>1995</year><volume>13</volume><fpage>323-330</fpage><lpage>307-308</lpage><pub-id pub-id-type="pmid">8603061</pub-id><pub-id pub-id-type="doi">10.1016/0263-7855(95)00073-9</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bayer</surname><given-names>EA</given-names></name><name><surname>Ehrlich-Rogozinski</surname><given-names>S</given-names></name><name><surname>Wilchek</surname><given-names>M</given-names></name></person-group><article-title>Sodium dodecyl sulfate-polyacrylamide gel electrophoretic method for assessing the quaternary state and comparative thermostability of avidin and streptavidin</article-title><source>Electrophoresis</source><year>1996</year><volume>17</volume><fpage>1319</fpage><lpage>1324</lpage><pub-id pub-id-type="pmid">8874057</pub-id><pub-id pub-id-type="doi">10.1002/elps.1150170808</pub-id></citation></ref><ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>M</given-names></name><name><surname>Bagatolli</surname><given-names>LA</given-names></name><name><surname>Echabe</surname><given-names>I</given-names></name><name><surname>Arrondo</surname><given-names>JLR</given-names></name><name><surname>Argarana</surname><given-names>CE</given-names></name><name><surname>Cantor</surname><given-names>CR</given-names></name><name><surname>Fidelio</surname><given-names>GD</given-names></name></person-group><article-title>Interaction of biotin with streptavidin. Thermostability and conformational changes upon binding</article-title><source>J Biol Chem</source><year>1997</year><volume>25</volume><fpage>11288</fpage><lpage>11294</lpage></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waner</surname><given-names>MJ</given-names></name><name><surname>Navrotskaya</surname><given-names>I</given-names></name><name><surname>Bain</surname><given-names>A</given-names></name><name><surname>Oldham</surname><given-names>ED</given-names></name><name><surname>Mascotti</surname><given-names>DP</given-names></name></person-group><article-title>Thermal and sodium dodecylsulfate induced transitions of streptavidin</article-title><source>Biophys J</source><year>2004</year><volume>87</volume><fpage>2701</fpage><lpage>2713</lpage><pub-id pub-id-type="pmid">15298874</pub-id><pub-id pub-id-type="doi">10.1529/biophysj.104.047266</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>The X-ray structure of AVR2. </bold>(A) Multiple sequence alignment of the avidin family. The secondary structure elements are numbered according to the AVR2 structure. The residues mutated in this study (AVR2, Ile-109; AVR4, Lys-109; AVR6, Cys-58) are coloured green. Residue Cys-122 in AVR4, which was mutated to serine in a previous study [36], is indicated in blue. (B) Two tetramers found in the asymmetric unit of the AVR2-b crystal. (C) Monomer A of AVR2-b. The weighted difference <italic>F</italic><sub>o </sub>&#x02013; <italic>F</italic><sub>c </sub>electron density map (blue), calculated in the absence of biotin, is drawn with a 1.5 &#x000c5; radius around the atoms of D-biotin of the final structure of AVR2-b. Contours are shown at 3.0&#x003c3;. The secondary structure elements of AVR2-b are numbered. (D) A close-up view of (C) focused on biotin.</p></caption><graphic xlink:href="1472-6750-5-28-1"></graphic></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Biotin-binding sites of avidin, AVR2 and AVR4. </bold>Stereo images of the biotin-binding sites of (A) AVR2-b, (B) AVR4 [PDB:1Y52] [38] and (C) avidin [PDB:1AVD] [26] are shown. The cavities (transparent) around the bound biotin molecules of subunit A are shown. The water molecules within the cavities are shown as red spheres. Hydrogen bonds between the atoms of D-biotin and the surrounding proteins are shown with dashed lines. Carbon atoms of residues from subunit 1 are coloured white; those from a neighbouring subunit 2 are indicated in cyan: residues 108 and 109 (110 and 111 in avidin).</p></caption><graphic xlink:href="1472-6750-5-28-2"></graphic></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>The 1&#x02013;3 subunit interface of AVR2, AVR4 and avidin. </bold>Stereo images of the 1&#x02013;3 subunit interface of (A) AVR2-b, (B) AVR4 [PDB:1Y52] [38], and of (C) avidin expressed in <italic>E. coli </italic>[PDB:1VYO] (Airenne, Hyt&#x000f6;nen <italic>et al. </italic>unpublished) are shown. Lys-94 of AVR2 exists in two alternate conformations, which can form a hydrogen bond with the side-chain oxygen atom of Asn-115 or with the main-chain oxygen atom of Val-113, both from an adjacent subunit. Putative hydrogen bonds are shown by dashed lines. The carbon atoms of subunits 1 and 3 are coloured white and cyan, respectively.</p></caption><graphic xlink:href="1472-6750-5-28-3"></graphic></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Biotin dissociation analysis. </bold>(A) Temperature-dependence of biotin dissociation rates measured by the [<sup>3</sup>H]biotin dissociation assay. Radiobiotin dissociation rate constants measured for the proteins are plotted as a function of temperature. The models for dissociation rate constants obtained by global fit analysis [41] are shown by lines and the determined individual dissociation rates by symbols. The dissociation rate constants determined previously for avidin and AVR4-b are also shown [39]. (B) Relative dissociation rate constants of the AVRs and avidin mutant K111I compared to that of avidin. The individual dissociation rates as well as global fit analysis models of the dissociation rate are divided by the dissociation rate constants of avidin obtained from global fit analysis. The data are plotted using a logarithmic y-axis.</p></caption><graphic xlink:href="1472-6750-5-28-4"></graphic></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Summary of the biochemical properties and phylogeny of avidin (AVD) and the AVRs. </bold>The putative chicken biotin-binding proteins BBP-A and BBP-B [12] as well as streptavidin (STR) are included. The confidence levels of the branching of the phylogenetic tree were assessed using the bootstrap method [64]. The tree is unrooted and the branch lengths are not to scale. The values at each node represent the percentage of the 1000 trees where the species above the node are consistently found. T<sub>m</sub>(-), heat-induced unfolding temperature without D-biotin (&#x000b0;C). T<sub>m</sub>(+), heat-induced unfolding temperature in the presence of D-biotin (&#x000b0;C). T<sub>r</sub>(-), transition temperature of oligomeric disassembly without D-biotin determined using SDS-PAGE assay (&#x000b0;C) [70]. T<sub>r</sub>(+), transition temperature of oligomeric disassembly in the presence of D-biotin (&#x000b0;C). k<sub>diss</sub>, biotin dissociation rate constant (&#x000d7; 10<sup>-6 </sup>s<sup>-1</sup>) obtained from global fitting [41] of the <sup>3</sup>H-biotin dissociation data. I1&#x02013;3, three residues important for the 1&#x02013;3 subunit interface (equivalent to residues 94, 113 and 115 in AVR2). The residues in BBP-A and BBP-B are numbered according to avidin. N. D., not determined. <sup>a</sup>Hyt&#x000f6;nen VP, unpublished data. Analysis performed on wt proteins produced in the baculovirus expression system as described in Ref. [35]. <sup>b</sup>From Ref. [70]. <sup>c</sup>From Ref. [36]. <sup>d</sup>From Ref. [71]. <sup>e</sup>From Ref. [72].</p></caption><graphic xlink:href="1472-6750-5-28-5"></graphic></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>The recombinant proteins of this study. The immobilised ligand used for affinity chromatography purification and the elution conditions are shown. Protein eluted using acetic acid was immediately dialyzed against 50 mM NaPO<sub>4 </sub>pH 7.0 + 100 mM NaCl.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Protein</td><td align="left">Affinity chromatography ligand</td><td align="left">Elution conditions</td><td align="left">Expression system</td><td align="left">Production yield (mg/l)<sup>a</sup></td></tr></thead><tbody><tr><td align="left">AVR2</td><td align="left">D-biotin</td><td align="left">0.5 M acetic acid</td><td align="left">BEVS<sup>b</sup></td><td align="left">0.8</td></tr><tr><td align="left">AVR2-b</td><td align="left">D-biotin</td><td align="left">0.5 M acetic acid</td><td align="left"><italic>E. coli</italic><sup>c</sup></td><td align="left">4.9</td></tr><tr><td align="left">AVR2(I109K)</td><td align="left">D-biotin</td><td align="left">0.5 M acetic acid</td><td align="left">BEVS</td><td align="left">9.0</td></tr><tr><td align="left">AVR4<sup>d</sup></td><td align="left">2-iminobiotin</td><td align="left">50 mM Na-Ac + 100 mM NaCl</td><td align="left">BEVS</td><td align="left">6.1</td></tr><tr><td align="left">AVR4-b<sup>d</sup></td><td align="left">2-iminobiotin</td><td align="left">50 mM Na-Ac + 100 mM NaCl</td><td align="left"><italic>E. coli</italic></td><td align="left">21.9</td></tr><tr><td align="left">AVR4(K109I)<sup>d</sup></td><td align="left">2-iminobiotin</td><td align="left">50 mM Na-Ac + 100 mM NaCl</td><td align="left">BEVS</td><td align="left">16.2</td></tr><tr><td align="left">AVR4(K109I)-b<sup>d</sup></td><td align="left">2-iminobiotin</td><td align="left">50 mM Na-Ac + 100 mM NaCl</td><td align="left"><italic>E. coli</italic></td><td align="left">6.7</td></tr><tr><td align="left">AVR6-b<sup>e</sup></td><td align="left">D-biotin</td><td align="left">2 M acetic acid</td><td align="left"><italic>E. coli</italic></td><td align="left">8.3</td></tr><tr><td align="left">AVD(K111I)</td><td align="left">2-iminobiotin</td><td align="left">50 mM Na-Ac + 100 mM NaCl</td><td align="left">BEVS</td><td align="left">11.5</td></tr><tr><td align="left">AVD(K111I)-b</td><td align="left">2-iminobiotin</td><td align="left">50 mM Na-Ac + 100 mM NaCl</td><td align="left"><italic>E. coli</italic></td><td align="left">0.7</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>After affinity chromatography per one liter of culture medium. The yields are calculated based on only a few protein purifications.</p><p><sup>b</sup>Produced using a baculovirus expression system in insect cells as described previously [40].</p><p><sup>c</sup>The bacterial signal peptide from the protein OmpA was utilised in order to produce the protein in an active form in <italic>E. coli </italic>as described in [37].</p><p><sup>d</sup>AVR4 is identical to AVR5. The protein carries the mutation C122S, which prevents oligomerisation <italic>via </italic>intermolecular disulphide bridges [36].</p><p><sup>e</sup>Carries mutation C58S, which prevents oligomerisation <italic>via </italic>intermolecular disulphide bridges (this study).</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Structural properties of avidin and avidin related proteins. Elution times from FPLC gel filtration and calculated molecular weights of the proteins. Heat-induced unfolding temperatures of proteins from DSC analysis (average &#x000b1; S.D).</p></caption><table frame="hsides" rules="groups"><tbody><tr><td></td><td align="center" colspan="2"><bold>Gel filtration</bold></td><td align="center" colspan="3"><bold>DSC</bold></td></tr><tr><td></td><td colspan="5"><hr></hr></td></tr><tr><td align="center"><bold>Protein</bold></td><td align="center"><bold>Elution time (min)</bold></td><td align="center"><bold>Molecular mass (kDa)</bold></td><td align="center"><bold>T<sub>m </sub>(-biotin) (&#x000b0;C)</bold></td><td align="center"><bold>T<sub>m </sub>(+biotin) (&#x000b0;C)</bold></td><td align="center"><bold>&#x00394;T<sub>m</sub><sup>a </sup>(&#x000b0;C)</bold></td></tr><tr><td></td><td colspan="5"><hr></hr></td></tr><tr><td align="center"><bold>AVD<sup>b</sup></bold></td><td align="center">31.5</td><td align="center">46.5</td><td align="center">83.5 &#x000b1; 0.1</td><td align="center">117.0 &#x000b1; 0.7</td><td align="center">33.5</td></tr><tr><td align="center"><bold>AVD(K111I)</bold></td><td align="center">31.9</td><td align="center">42.1</td><td align="center">76.5 &#x000b1; 0.1</td><td align="center">116.0 &#x000b1; 0.1</td><td align="center">39.5</td></tr><tr><td align="center"><bold>AVR2</bold></td><td align="center">30.1</td><td align="center">66.6</td><td align="center">91.3</td><td align="center">112.5</td><td align="center">21.2</td></tr><tr><td align="center"><bold>AVR2(I109K)</bold></td><td align="center">30.0</td><td align="center">68.2</td><td align="center">97.6 &#x000b1; 0.1</td><td align="center">118.7 &#x000b1; 0.1</td><td align="center">21.1</td></tr><tr><td align="center"><bold>AVR2-b</bold></td><td align="center">30.9</td><td align="center">55.1</td><td align="center">93.4 &#x000b1; 0.4</td><td align="center">112.5</td><td align="center">19.1</td></tr><tr><td align="center"><bold>AVR4<sup>c</sup></bold></td><td align="center">31.9</td><td align="center">42.1</td><td align="center">106.4 &#x000b1; 0.8</td><td align="center">125.4 &#x000b1; 0.8</td><td align="center">19.0</td></tr><tr><td align="center"><bold>AVR4(K109I)</bold></td><td align="center">31.3</td><td align="center">49.8</td><td align="center">104.5 &#x000b1; 0.5</td><td align="center">118.6 &#x000b1; 1.2</td><td align="center">14.1</td></tr><tr><td align="center"><bold>AVR6-b</bold></td><td align="center">31.1</td><td align="center">51.5</td><td align="center">87.7</td><td align="center">114.0</td><td align="center">26.3</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>&#x00394;T<sub>m </sub>is the change in T<sub>m </sub>upon addition of a three-fold molar excess of D-biotin.</p><p><sup>b</sup>DSC results for avidin are from Ref [61].</p><p><sup>c</sup>DSC results for AVR4 are from Ref [36].</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Data collection and structure determination statistics for AVR2.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Data collection<sup>a</sup></td><td></td></tr></thead><tbody><tr><td align="left">&#x02003;Wavelength (&#x000c5;)</td><td align="center">0.934</td></tr><tr><td align="left">&#x02003;Beamline</td><td align="center">ID14-1 (ESRF)</td></tr><tr><td align="left">&#x02003;Detector</td><td align="center">ADSC Q4R CCD</td></tr><tr><td align="left">&#x02003;Resolution (&#x000c5;)</td><td align="center">25 &#x02013; 1.40 (1.50 &#x02013; 1.40)</td></tr><tr><td align="left">&#x02003;Unique observations</td><td align="center">257876 (47505)</td></tr><tr><td align="left">&#x02003;I/sigma</td><td align="center">14.3 (3.2)</td></tr><tr><td align="left">&#x02003;<italic>R</italic><sub>sym</sub><sup>b </sup>(%)</td><td align="center">7.2 (54.6)</td></tr><tr><td align="left">&#x02003;Completeness</td><td align="center">99.6 (99.0)</td></tr><tr><td align="left">&#x02003;Redundancy</td><td align="center">6.0 (5.9)</td></tr><tr><td colspan="2"><hr></hr></td></tr><tr><td align="left">Refinement</td><td></td></tr><tr><td colspan="2"><hr></hr></td></tr><tr><td align="left">&#x02003;Space group</td><td align="center"><italic>P</italic>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub></td></tr><tr><td align="left">&#x02003;Unit cell:</td><td></td></tr><tr><td align="left">&#x02003;&#x02003;a, b, c (&#x000c5;)</td><td align="center">97.7, 99.9, 135.2</td></tr><tr><td align="left">&#x02003;&#x02003;&#x003b1;, &#x003b2;, &#x003b3; (&#x000b0;)</td><td align="center">90, 90, 90</td></tr><tr><td align="left">&#x02003;Monomers (asymmetric unit)</td><td align="center">8</td></tr><tr><td align="left">&#x02003;Resolution (&#x000c5;)</td><td align="center">25 &#x02013; 1.40</td></tr><tr><td align="left">&#x02003;<italic>R</italic><sub>work</sub><sup>c </sup>(%)</td><td align="center">17.4</td></tr><tr><td align="left">&#x02003;<italic>R</italic><sub>free</sub><sup>c,d </sup>(%)</td><td align="center">20.1</td></tr><tr><td align="left">&#x02003;Protein atoms</td><td align="center">7720</td></tr><tr><td align="left">&#x02003;Heterogen. atoms</td><td align="center">234</td></tr><tr><td align="left">&#x02003;Solvent atoms</td><td align="center">1168</td></tr><tr><td align="left">&#x02003;<italic>R.m.s.d:</italic></td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Bond lengths (&#x000c5;)</td><td align="center">0.015</td></tr><tr><td align="left">&#x02003;&#x02003;Bond angles (&#x000b0;)</td><td align="center">1.7</td></tr><tr><td align="left">Ramachandran plot:</td><td></td></tr><tr><td align="left">&#x02003;Residues in most favored regions</td><td align="center">94.3%</td></tr><tr><td align="left">&#x02003;Residues in additional allowed regions</td><td align="center">5.7%</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>The numbers in parenthesis refer to the highest resolution bin.</p><p><sup>b</sup><graphic xlink:href="1472-6750-5-28-i1.gif"/></p><p><sup>c</sup><graphic xlink:href="1472-6750-5-28-i2.gif"/></p><p><sup>d</sup>Performed on 5% of the reflections.</p></table-wrap-foot></table-wrap></sec></back></article> 